-
Xiaomi Pad 9 Pro Leak Suggests 12.5-Inch Display and Massive Battery
-
China's Xi and Iran's Pezeshkian in Kyrgyzstan, Putin expected
-
UK Homeowners Advised to Use Peppermint Tea Bags to Deter Spiders
-
Rescuers hunt for missing after deadly N.Cyprus ferry accident
-
Nepal toll surges as rescuers struggle through 'unimaginable' disaster
-
Ethiopia's Abiy could consolidate power as 'executive president'
-
Mauled Australian swimmer recalls punching shark
-
Crude prices rise on US-Iran strikes, equities mixed after Warsh remarks
-
Passengers stranded overnight by Kenya airport strike
-
South Korea court gives Unification Church leader 2 years prison
-
Nepal recovers bodies but presses on for trapped tunnel workers
-
US hosts G20 finance talks with growth, Iran pressure on agenda
-
Grand Canyon flash flood leaves one dead, around 15 missing
-
African players in Europe: Wissa flick seals Newcastle victory
-
Venus Williams falls at first hurdle in US Open
-
Venice film preview: Clooney, Oasis and Musk
-
At least five leaders skip annual Pacific Islands summit
-
Poorly Djokovic crashes out of US Open first round
-
I.Coast home-hunters' saga highlights Africa housing crunch
-
Djokovic falls in US Open first round, earliest Grand Slam exit in 20 years
-
At least five leaders to skip annual Pacific Islands summit
-
Chinese guitar capital's stairway to export heaven
-
Latest developments in the US-Iran war
-
Stocks drop as Warsh fans US rate hike bets, crude up on US-Iran strikes
-
Nepal buries dead as rescuers seek thousands missing
-
Injuries cloud tennis as US Open gets under way
-
From Montecito to the Cotswolds: Harry and Meghan eye new UK home
-
Iran retaliates after first US strikes in a month
-
Russia's Putin and China's Xi to attend summit in Kyrgyzstan
-
Itauma says 'I'll be back' after bruising heavyweight title loss
-
John Ternus to lead Apple into the age of AI
-
Brilliant Palou clinches fourth straight IndyCar crown
-
Trump calls for 'punishment' of NBC reporter
-
EN China XLX Announces 2026 Interim Results
-
US strikes Iran for first time in a month, Tehran retaliates
-
About 15 people missing after Grand Canyon flash flood
-
Yin holds off Kim to win sixth LPGA title, end title drought
-
Medvedev advances without drama at US Open
-
Top-ranked Scheffler storms to PGA Tour Championship win
-
Calhanoglu fires Inter to nervy Cagliari win, Como stun Napoli
-
Root urges England to be 'grown-ups' after Pakistan series win
-
Monaco beat Marseille to go top, Rosenior's Paris FC thump Nice
-
Google Maps renames Lake Ontario 'Lake America' in US -- but not Canada
-
Pegula shakes off nerves in US Open first-round win
-
Aaron Donald ends retirement to rejoin Rams: team
-
FIFA president Infantino 'must go', says ex-UEFA boss Platini
-
Niamey back to normal after soldiers' mutiny
-
England v Pakistan second Test: Three talking points
-
Niger mutiny suppressed, but questions remain over junta's cohesion
-
Rashford's return 'fantastic' for Man Utd, says Carrick
Lantern Pharma Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / July 25, 2025 / RedChip Companies will air an interview with Lantern Pharma Inc. (Nasdaq:LTRN) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 26, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Access the interview in its entirety at: https://www.redchip.com/assets/access/ltrn_access
In an exclusive interview, Panna Sharma, CEO of Lantern Pharma, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss how Lantern is redefining oncology drug development through its proprietary AI platform, RADR®. Sharma highlights Lantern's clinical-stage programs (LP-300, LP-184, and LP-284) which address high-need indications such as NSCLC in never-smokers, DDR-deficient solid tumors, and aggressive lymphomas. He also shares how Lantern's capital-efficient AI-driven model, which has enabled 12 oncology programs in just two years at a fraction of traditional development costs, is driving rapid value creation. With multiple upcoming clinical readouts, an expanding AI-driven pipeline, and over 100 issued and pending patents, Lantern is positioned as a next-generation biotech innovator at the intersection of artificial intelligence and precision oncology.
LTRN is a client of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.
About Lantern Pharma
Lantern Pharma (NASDAQ:LTRN) is an AI-driven biotechnology company focused on accelerating and optimizing the discovery, development, and commercialization of cancer therapies. Its RADR® platform leverages artificial intelligence and machine learning to uncover novel therapeutic opportunities, accelerate drug development, and improve patient outcomes.
Please find more information at:
Website: www.lanternpharma.com
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.
To learn more about RedChip's products and services, please visit:
https://www.redchip.com/corporate/investor_relations
"Discovering Tomorrow's Blue Chips Today"™
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
Follow RedChip on Twitter: https://twitter.com/RedChip
Follow RedChip on YouTube: https://www.youtube.com/@redchip
Follow RedChip on Rumble: https://rumble.com/c/c-3068340
Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest
Contact:
Dave Gentry
RedChip Companies Inc.
1-407-644-4256
[email protected]
--END--
SOURCE: RedChip Companies, Inc. (Media Suite)
View the original press release on ACCESS Newswire
H.Romero--AT